Company intelligence / Profile preview

NS Investment

Seoul, South Korea

Ownership: Private
Development stage: Other

Overview

NS Investment is a South Korea–based venture capital firm (founded 2016) that invests heavily in biotechnology and therapeutics companies, commonly co‑investing with leading life science funds such as OrbiMed, Sofinnova, The Column Group, and Taiho Ventures.[1][5]

Industry: Investors

Partnerships

Co‑investments with OrbiMedCo‑investments with The Column GroupCo‑investments with Sofinnova InvestmentsCo‑investments with Taiho VenturesInvestor in Aspen Neuroscience

Beyond the preview

Go deeper on NS Investment.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NS Investment.

Explore the full profile